Results 251 to 260 of about 3,117,334 (404)

Transformer-based deep learning enhances discovery in migraine GWAS. [PDF]

open access: yesNat Commun
Meng Z   +7 more
europepmc   +1 more source

TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Background The transient receptor potential melastatin 3 (TRPM3) ion channel has been implicated in sensory modulation and pain transmission and may contribute to migraine pathophysiology through calcitonin gene‐related peptide (CGRP) release in the trigeminovascular system. This study aimed to investigate TRPM3 activation and its role in CGRP
Philip V. Reducha   +9 more
wiley   +1 more source

Molecular genetic overlap between migraine and major depressive disorder [PDF]

open access: bronze, 2018
Yuanhao Yang   +17 more
openalex   +1 more source

Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statement

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to review the published literature and provide a position statement from the American Headache Society regarding the safety, efficacy, and impact on access to care of telemedicine for the clinical management of patients with headache disorders.
Karissa N. Arca   +6 more
wiley   +1 more source

The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders [PDF]

open access: gold, 2014
Marcos F. DosSantos   +4 more
openalex   +1 more source

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy